{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:41:12Z","timestamp":1777538472960,"version":"3.51.4"},"reference-count":33,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2024,9,18]]},"DOI":"10.1080\/10428194.2024.2371474","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T11:28:10Z","timestamp":1719833290000},"page":"1716-1723","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Cytomegalovirus infection risk with alemtuzumab therapy in hematological malignancies: a retrospective cohort study in the non-transplant setting"],"prefix":"10.1080","volume":"65","author":[{"given":"Joel","family":"George","sequence":"first","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Mozessohn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto","place":["Toronto, Canada"]},{"name":"Division of Hematology\/Medical Oncology, Sunnybrook Health Sciences Centre","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-4660","authenticated-orcid":false,"given":"Philip W.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Temerty Faculty of Medicine, University of Toronto","place":["Toronto, Canada"]},{"name":"Division of Infectious Diseases, Sunnybrook Health Sciences Centre","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,7]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.29245\/2578-3009\/2019\/4.1178"},{"key":"e_1_3_3_3_1","volume-title":"Adverse Events with Biomedicines","author":"Tridente G.","year":"2013","unstructured":"Tridente G. Alemtuzumab. Adverse Events with Biomedicines. 2013, Chapter 7, pages 81-95, Springer, Milano, Print ISBN: 978-88-470-5312-0 Online ISBN: 978-88-470-5313-7, https:\/\/link.springer.com\/chapter\/10.1007\/978-88-470-5313-7_7#citeas."},{"issue":"5","key":"e_1_3_3_4_1","first-page":"364","article-title":"Alemtuzumab: what Is the Secret to Safe Therapy?","volume":"9","author":"Elter T","year":"2011","unstructured":"Elter T, Hallek M, Montillo M. Alemtuzumab: what Is the Secret to Safe Therapy? Clin Adv Hematol Oncol. 2011;9(5):364\u2013373.","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12002"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12428"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1086\/319225"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13512"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3138"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.584991"},{"issue":"10","key":"e_1_3_3_11_1","first-page":"1248","article-title":"Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir","volume":"89","author":"Laurenti L","year":"2004","unstructured":"Laurenti L, Piccioni P, Cattani P, et\u00a0al. Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir. Hematologica. 2004;89(10):1248\u20131252.","journal-title":"Hematologica"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30107-0"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2006.n.049"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.6688"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0159"},{"key":"e_1_3_3_16_1","volume-title":"World Health Organization classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris, NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. World Health Organization classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC; 2008.","edition":"4"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-017-0180-z"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23031"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.10.77"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.11.008"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00289-6"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.05.001"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40506-021-00253-w"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.10.037"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0566-9"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24188"},{"key":"e_1_3_3_28_1","unstructured":"Fraser G Haynes AE Kouroukis CT et\u00a0al. Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia. Cancer Care Ontario. 2007; Program in Evidence-based Care CED-CCO Advice Report No.: 6-22."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152611797636703"},{"issue":"1","key":"e_1_3_3_30_1","first-page":"435","article-title":"Cytomegalovirus reactivation during alemtuzumab therapy for CLL: safety and efficacy of valganciclovir","volume":"91","author":"Lucania A","year":"2006","unstructured":"Lucania A, Villa MR, Improta S, et\u00a0al. Cytomegalovirus reactivation during alemtuzumab therapy for CLL: safety and efficacy of valganciclovir. Hematologica. 2006;91(s1):435.","journal-title":"Hematologica"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.740079"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.303"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad386"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.06.119"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2024.2371474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:33:04Z","timestamp":1768206784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2024.2371474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,9,18]]}},"alternative-id":["10.1080\/10428194.2024.2371474"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2024.2371474","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}